Transcutaneous bilirubin curves in healthy neonates based on multicenter remote monitoring data
10.3760/cma.j.cn112140-20250710-00601
- VernacularTitle:基于多中心远程监测的健康新生儿经皮胆红素动态曲线研究
- Author:
Bi ZE
1
;
Xiaoyue DONG
;
Jin WANG
;
Chuan NIE
;
Jiajun ZHU
;
Fang GUO
;
Falin XU
;
Chunhui YANG
;
Bizhen SHI
;
Zhankui LI
;
Xinhua ZHANG
;
Jing LI
;
Bin YI
;
Xiuying TIAN
;
Lejia ZHANG
;
Jun TANG
;
Xinlin HOU
;
Jiahua XU
;
Guoying HUANG
;
Shuping HAN
;
Wenhao ZHOU
Author Information
1. 国家儿童医学中心 复旦大学附属儿科医院新生儿科，上海 201102
- Publication Type:Journal Article
- Keywords:
Bilirubin;
Non-invasive detection;
Telemedicine;
Neonate
- From:
Chinese Journal of Pediatrics
2025;63(12):1318-1324
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To establish 30-day of age transcutaneous bilirubin (TcB) reference curves for healthy neonates, and to investigate regional variations in bilirubin dynamics.Methods:A multicenter retrospective cohort study was conducted. A total of 220 950 healthy neonates born at a gestational age of 35-<42 weeks, with a birth weight ≥2 000 g, who did not receive phototherapy within 60 h after birth were recruited. All of them underwent remote TcB monitoring using the Bilibaby remote jaundice monitoring system between August 1 st, 2020 and December 31 st, 2024 in 426 hospitals. TcB data were collected within the period from birth to 30-day of age. The P40, P75, and P95 of TcB values were calculated, and dynamic TcB curves for 30-day of age were constructed. Patterns of bilirubin change, rates of change, and transition outcomes were described. Regional comparisons between South and North were conducted using linear mixed-effects models for TcB trajectories and Pearson′s chi-square test for outcome differences. Results:A total of 220 950 neonates were included, of whom 101 711 (46.03%) were female. Gestational age at birth was (38.75±1.12) weeks, and birth weight was (3 272±417) g. TcB levels increased rapidly within 3-day of age, peaked at 4-6-day of age, with peak values at P40, P75, and P95 of 200.6, 239.7 and 275.4 μmol/L (11.8, 14.1 and 16.2 mg/dl), respectively. TcB levels gradually declined thereafter and stabilized after 13-day of age, with values at P40, P75, and P95 fluctuating between 147.9-159.8, 190.4-200.6, and 231.2-239.7 μmol/L (8.7-9.4, 11.2-11.8, 13.6-14.1 mg/dl), respectively. Notably, among neonates categorized as low-or low-intermediate-risk within 3-day of age, 6 700 (12.76%) progressed to intermediate-high or high risk between 4 and 30 days of age. Before 13-day of age, TcB levels in the southern regions were consistently higher than those in the northern regions ( P=0.039); from 14 to 30 days of age, the overall TcB levels had no statistically difference, but the temporal changes in TcB still showed regional differences (degrees of freedom=3, all interaction P<0.05). Among neonates classified as low-or low-intermediate risk within 3-day of age, 25 326 were from southern regions, of whom 4 254 (16.80%) progressed to intermediate-high or high risk between 4 and 30 days of age. In northern regions, 27 193 neonates were classified as low-or low-intermediate risk within 3-day of age, among whom 2 446 (8.99%) progressed to intermediate-high or high risk. The risk progression between the 2 regions had statistically difference ( χ2=716.49, P<0.001). Conclusions:A TcB percentile curve for neonates within 30-day of age was established, revealing that both the overall TcB level and its temporal trend were higher in southern than in northern newborns. These findings provide baseline data to support continuous management of neonatal jaundice.
